DOI QR코드

DOI QR Code

Comparison of Infection between Internal-External and External Percutaneous Transhepatic Biliary Drainage in Treating Patients with Malignant Obstructive Jaundice

  • Xu, Chuan (Department of Interventional Radiology, Subei People's Hospital of Jiangsu Province, Clinical Hospital of Yangzhou University) ;
  • Huang, Xin-En (Department of Chemotherapy, Jiangsu Cancer Hospital, Nanjing Medical University) ;
  • Wang, Shu-Xiang (Department of Interventional Radiology, Subei People's Hospital of Jiangsu Province, Clinical Hospital of Yangzhou University) ;
  • Lv, Peng-Hua (Department of Interventional Radiology, Subei People's Hospital of Jiangsu Province, Clinical Hospital of Yangzhou University) ;
  • Sun, Ling (Department of Interventional Radiology, Subei People's Hospital of Jiangsu Province, Clinical Hospital of Yangzhou University) ;
  • Wang, Fu-An (Department of Interventional Radiology, Subei People's Hospital of Jiangsu Province, Clinical Hospital of Yangzhou University)
  • 발행 : 2015.04.03

초록

Purpose: Percutaneous transhepatic biliary drainage (PTBD) is a form of palliative care for patients with malignant obstructive jaundice. We here compared the infection incidence between internal-external and external drainage for patients with malignant obstructive jaundice. Methods: Patients with malignant obstructive jaundice without infection before surgery receiving internal-external or external drainage from January 2008 to July 2014 were recruited. According to percutaneous transhepatic cholangiography (PTC), if the guide wire could pass through the occlusion and enter the duodenum, we recommended internal-external drainage, and external drainage biliary drainage was set up if the occlusion was not crossed. All patients with infection after procedure received a cultivation of blood and a bile bacteriological test. Results: Among 110 patients with malignant obstructive jaundice, 22 (52.4%) were diagnosed with infection after the procedure in the internal-external drainage group, whereas 19 (27.9%) patients were so affected in the external drainage group, the difference being significant (p<0.05). In 8 patients (36.3%) in the internal-external group infection was controlled, as compared to 12 (63.1%) in the external group (p< 0.05). The mortality rate for patients with infection not controlled in internal-external group in one month was 42.8%, while this rate in external group was 28.6% (p< 0.05). Conclusion: External drainage is a good choice, which could significantly reduce the chance of biliary infection caused by bacteria, and decrease the mortality rate at one month and improve the long-term prognosis.

키워드

참고문헌

  1. Boursier J, Cesbron E, Tropet AL, et al (2009). Comparison and improvement of MELD and Child-Pugh score accuracies for the predietion of 6-month mortality in cirrhotic patients. J Clin Gastroenterol, 43, 580-5. https://doi.org/10.1097/MCG.0b013e3181889468
  2. Dambraukas Z, Paskauskas S, Lizdenis P, et al (2003). Percutaneous transhepatic biliary stenting: the first experience and results of the Hospital of Kaunas University of Medicine. Med, 44, 969-76.
  3. De Jong EA, Moelker A, Leertouwer T, et al (2013). Percutaneous transhepatic biliary drainage in patients with postsurgical bile leakage and nondilated intrahepatic bile ducts. Dig Surg, 30, 444-50. https://doi.org/10.1159/000356711
  4. Englesbe MJ, Dawes LG (2005). Resistant pathogen in biliary obstruction: importance of cultures to guide antibiotic therapy. HPB, 7, 144-8. https://doi.org/10.1080/13651820510028792
  5. Herzog T, Belyaev O, Hessam S, et al (2012). Bacteribilia with resistant microorganisms after preoperative biliary drainage the influence of bacteria on postoperative outcome. Scand J Gastroenterol, 47, 827-35. https://doi.org/10.3109/00365521.2012.679684
  6. Ho CS, Warkentin AE (2013). Evidence-based decompression in malignant biliary obstruction. Korean J Radiol, 13, S56-61.
  7. Jong Kyoung Choi, Ji Kon Kyu, et al (2013). Palliative treatment of unresectable hepatocellular carcinoma with obstructive jaundice using biliary drainage with subsequent transarterial chemoembolization. J Palliat Med, 16, 1026-33. https://doi.org/10.1089/jpm.2013.0067
  8. Kawakami H, Kondo S, Kuwatani M, et al (2011). Preoperative biliary drainage for hilar cholangiocarcinoma: which stent should be selected? J Hepatobiliary Pancreat Sci, 18, 630-5. https://doi.org/10.1007/s00534-011-0404-7
  9. Kaya M, Bestas R, Bacalan F, et al (2012). Microbial profile and antibiotic sensitivity pattern in bile cultures from endoscopic retrograde cholangiography patients. World J Gastroenterol, 18, 3585-9. https://doi.org/10.3748/wjg.v18.i27.3585
  10. Li Sol Y, Kim CW, Jeon UB, et al (2010). Early infectious complications of percutaneous metallic stent insertion for malignant biliary obstruction. AJR Am J Roentgenol, 194, 261-5. https://doi.org/10.2214/AJR.09.2474
  11. Lofts FJ, Evans TR, Mansi JL, Glees JP, Knight MJ (1997). Bile duct stents: is there an increased rate of complications in patients receiving chemotherapy? Eur J Cancer, 33, 209-13. https://doi.org/10.1016/S0959-8049(96)00365-6
  12. Namias N, Demoya M, Sleeman D, et al (2005). Risk of postoperative infection in patients with bactibilia undergoing surgery for obstructive jaundice. Surg Infect, 6, 323-8. https://doi.org/10.1089/sur.2005.6.323
  13. Ozden I, Tekant Y, Bilge O, et al (2005). Endoscopic and radiologic interventions as the leading causes of severe cholangitis in a tertiary referral center. Am J Surg, 189, 702-6. https://doi.org/10.1016/j.amjsurg.2005.03.010
  14. Shin Ahn, Yoon-seon Lee, Kyung Soo Lin, et al (2013). Malignant biliary obstructions can we predict immediate postprocedural cholangitis after percutaneous biliary drainage? Support Care Cancer, 21, 2321-6. https://doi.org/10.1007/s00520-013-1796-5
  15. Simmons DT, Baron TH, Petersen BT, et al (2006). A novel endoscopic approach to brachytherapy in the management of Hilar cholangiocarcinoma. Am J Gastroenterol, 64, 1792-96.
  16. Thunyaharn N, Promthet S, Wiangnon S, et al (2013). Survival of cholangiocarcinoma patients in northeastern Thailand after supportive treatment. Asian Pac J Cancer Prev, 14, 7029-32. https://doi.org/10.7314/APJCP.2012.14.11.7029
  17. Todoroki T (2000). Chemotherapy for bile duct carcinoma in the light of adjuvant chemotherapy to surgery. Hepatogastroenterology, 47, 644-9.
  18. Westwood DA, Fernando C, Connor Sj, et al (2010). external percutaneous transhepatic billary drainage for malignant biliary obstruction: a retrospective analysis. J Med Imag Rad Oncol, 54, 108-10. https://doi.org/10.1111/j.1754-9485.2010.02147.x
  19. Xu C, Lv PH, Huang XE, et al (2014). Internal-external percutaneous transhepatic biliary drainage for patients with malignant obstructive jaundice. Asian Pac J Cancer Prev, 15, 9391-4. https://doi.org/10.7314/APJCP.2014.15.21.9391
  20. Xu C, Lv PH, Huang XE, et al (2014). Analysis of different ways of drainage for obstructive jaundice caused by hilar cholangiocarcinoma. Asian Pac J Cancer Prev, 15, 5617-20. https://doi.org/10.7314/APJCP.2014.15.14.5617
  21. Xu C, Huang XE, Wang SX, et al (2014). Drainage alone or combined with anti-tumor therapy for treatment of obstructive jaundice caused by recurrence and metastasis after primary tumor resection. Asian Pac J Cancer Prev, 15, 2681-4. https://doi.org/10.7314/APJCP.2014.15.6.2681
  22. Zhu HD, Guo JH, Teng GJ, et al (2012). A novel biliary loaded 125 I seeds in patients with malignant biliary obstruction: Preliminary results versus a conventional biliary stent. J Hepatol, 56, 1104-11 https://doi.org/10.1016/j.jhep.2011.12.018

피인용 문헌

  1. Safety and Efficacy of a Mouth-Rinse with Granulocyte Colony Stimulating Factor in Patients with Chemotherapy-Induced Oral Mucositis vol.17, pp.1, 2016, https://doi.org/10.7314/APJCP.2016.17.1.413
  2. A Clinical Study on Juheli (Recombinant Human Interleukin - 11) in the Second Prevention of Chemotherapy Induced Thrombocytopenia vol.17, pp.2, 2016, https://doi.org/10.7314/APJCP.2016.17.2.485
  3. Regarding “Risk Factors for Immediate and Delayed-Onset Fever After Percutaneous Transhepatic Biliary Drainage” vol.39, pp.5, 2016, https://doi.org/10.1007/s00270-016-1306-5
  4. Reply to the letter Regarding “Risk Factors for Immediate and Delayed-Onset Fever After Percutaneous Transhepatic Biliary Drainage” vol.39, pp.5, 2016, https://doi.org/10.1007/s00270-016-1307-4
  5. Comparison of Endoscopic Ultrasonography Guided Biliary Drainage and Percutaneous Transhepatic Biliary Drainage in the Management of Malignant Obstructive Jaundice After Failed ERCP vol.27, pp.6, 2017, https://doi.org/10.1097/SLE.0000000000000485
  6. Palliation of Malignant Biliary Obstruction: Adverse Events are Common After Percutaneous Transhepatic Biliary Drainage pp.1799-7267, 2017, https://doi.org/10.1177/1457496917731192